These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 17582564

  • 41. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN, Hatz C, Kantele A.
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [Abstract] [Full Text] [Related]

  • 42. A controlled field trial of liver oral typhoid vaccine Ty21a.
    Wahdan MH, Serie C, Germanier R, Lackany A, Cerisier Y, Guerin N, Sallam S, Geoffroy P, el Tantawi AS, Guesry P.
    Bull World Health Organ; 1980 Oct; 58(3):469-74. PubMed ID: 6998594
    [Abstract] [Full Text] [Related]

  • 43. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV, Mironova MV, Ryapolova RG.
    Acta Microbiol Acad Sci Hung; 1974 Oct; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract] [Full Text] [Related]

  • 44. [Is the oral typhoid-paratyphoid vaccination effective during an epidemic? Evaluation of a paratyphoid B epidemic in Bavaria, summer 1967].
    Freytag B, Koslik E, Marder E, Stickl H.
    Dtsch Med Wochenschr; 1969 May 09; 94(19):990-5. PubMed ID: 4976271
    [No Abstract] [Full Text] [Related]

  • 45. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E.
    N Engl J Med; 2009 Nov 26; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract] [Full Text] [Related]

  • 46. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
    Jain SK.
    Curr Opin Mol Ther; 2009 Oct 26; 11(5):565-71. PubMed ID: 19806505
    [Abstract] [Full Text] [Related]

  • 47. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
    Wang JY, Noriega FR, Galen JE, Barry E, Levine MM.
    Infect Immun; 2000 Aug 26; 68(8):4647-52. PubMed ID: 10899868
    [Abstract] [Full Text] [Related]

  • 48. [Diagnostic importance of various methods of determining infectious O-antigenemia in patients with typhoid and paratyphoid fevers A and B].
    Cherkasov VL, Rubtsov IV, Erovichenkov AA, Kulakov VN, Tregub AV.
    Ter Arkh; 1988 Aug 26; 60(11):35-8. PubMed ID: 2467391
    [Abstract] [Full Text] [Related]

  • 49. Efficacy of a live oral typhoid vaccine in human volunteers.
    Hornick RB, DuPont HL, Levine MM, Gilman RH, Woodward WE, Snyder MJ, Woodward TE.
    Dev Biol Stand; 1976 Aug 26; 33():89-92. PubMed ID: 782976
    [Abstract] [Full Text] [Related]

  • 50. Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains.
    Liu Q, Li P, Luo H, Curtiss R, Kong Q.
    Virulence; 2019 Dec 26; 10(1):82-96. PubMed ID: 31874075
    [Abstract] [Full Text] [Related]

  • 51. Vaccination against typhoid fever: present status.
    Ivanoff B, Levine MM, Lambert PH.
    Bull World Health Organ; 1994 Dec 26; 72(6):957-71. PubMed ID: 7867143
    [Abstract] [Full Text] [Related]

  • 52. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC, Agarwal N.
    Vaccine; 2008 Jan 17; 26(3):291. PubMed ID: 18082292
    [No Abstract] [Full Text] [Related]

  • 53. Vaccines for preventing typhoid fever.
    Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD001261. PubMed ID: 17636661
    [Abstract] [Full Text] [Related]

  • 54. The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
    Levine MM, Tacket CO, Herrington D, Losonsky G, Murphy J, Ferreccio C.
    Southeast Asian J Trop Med Public Health; 1988 Sep 18; 19(3):459-69. PubMed ID: 3064323
    [Abstract] [Full Text] [Related]

  • 55. Vaccine value profile for Salmonella enterica serovar Paratyphi A.
    Martin LB, Khanam F, Qadri F, Khalil I, Sikorski MJ, Baker S.
    Vaccine; 2023 Nov 03; 41 Suppl 2():S114-S133. PubMed ID: 37951691
    [Abstract] [Full Text] [Related]

  • 56. [The anti-Salmonella paratyphi B vaccination].
    Dimache G, Vlădoianu IR, Dimache V, Popescu P, Antonescu O, Mitrea D.
    Arch Roum Pathol Exp Microbiol; 1970 Sep 03; 29(3):477-86. PubMed ID: 4999244
    [No Abstract] [Full Text] [Related]

  • 57. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
    Tacket CO, Levine MM.
    Clin Infect Dis; 2007 Jul 15; 45 Suppl 1():S20-3. PubMed ID: 17582563
    [Abstract] [Full Text] [Related]

  • 58. Serodiagnosis of Salmonella enterica serovar Typhi and S. enterica serovars Paratyphi A, B and C human infections.
    Chart H, Cheasty T, de Pinna E, Siorvanes L, Wain J, Alam D, Nizami Q, Bhutta Z, Threlfall EJ.
    J Med Microbiol; 2007 Sep 15; 56(Pt 9):1161-1166. PubMed ID: 17761477
    [Abstract] [Full Text] [Related]

  • 59. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
    Acosta CJ, Galindo CM, Ali M, Elyazeed RA, Ochiai RL, Danovaro-Holliday MC, Page AL, Thiem VD, Jin Y, Park JK, Lee H, Puri MK, Ivanoff B, Agtini MD, Soeharno R, Simanjuntak CH, Punjabi NH, Canh DG, Sur D, Nizami Q, Manna B, Bai-qing D, Anh DD, Honghui Y, Bhattacharya SK, Bhutta Z, Trach DD, Xu ZY, Pang T, Donner A, Clemens JD.
    Trop Med Int Health; 2005 Dec 15; 10(12):1219-28. PubMed ID: 16359401
    [Abstract] [Full Text] [Related]

  • 60. [Typhoid and paratyphoid fever in children].
    Krogh K, Hermansen NO, Wathne KO.
    Tidsskr Nor Laegeforen; 2005 Jun 16; 125(12):1640-2. PubMed ID: 15976828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.